Want to join the conversation?
$V 3Q15 Call: Expect 4Q15 net revenue growth to approach double digit despite continuing foreign exchange rate headwinds and higher client incentive than 3Q15. Total operating expenses for 3Q15 were up 11% over the prior year. Expense growth rate will moderate from 3Q15 level with the full-year growth rate coming in the mid-single digit range.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.